logo

For the Inventor, By the Inventor

Cincinnati, OH, United States of America

Arthur D Sill

USPTO Granted Patents = 13

Average Co-Inventor Count = 2.6

ph-index = 4

Forward Citations = 25(Granted Patents)


Location History:

  • Greenhills, OH (US) (1976 - 1977)
  • Cincinnati, OH (US) (1976 - 1979)

Company Filing History:

goldMedal13 out of 167 
 
Richardson-merrell Inc.
 patents

Years Active: 1976-1979

Loading Chart...
13 patents (USPTO):Explore Patents
1. 4169897 - 2,7-Bis-basic ethers of 9-phenanthrol and 9-loweralkoxy phenanthrol (1979-10-02),
2. 4073904 - Bis-basic ethers of 2,6,- and 2,7-dihydroxy-anthraquinones (1978-02-14),
3. 4064347 - Bis-basic ketones of fluorene and fluorenone (1977-12-20),
4. 4048230 - Aminoacetyl-acenaphthenes (1977-09-13),
5. 4008240 - Xanthene and thioxanthene derivatives (1977-02-15),
6. 3983248 - Bis(aminoalkylsulfamoyl)anthraquinone antiviral agents (1976-09-28),
7. 3983124 - Fluorene compounds (1976-09-28),
8. 3974186 - Bis-basic ethers of 2,6- and 2,7-dihydroxyanthraquinones (1976-08-10),
9. 3957989 - Antiviral compositions containing bis-basic ketones of xanthene and (1976-05-18),
10. 3957988 - Antiviral compositions containing bis-basic ketones of thioxanthene (1976-05-18),
11. 3957986 - Antiviral compositions containing bis-basic esters and amides of (1976-05-18),
12. 3953455 - Derivatives of 6(5H)-phenanthridinone and a method for preparation (1976-04-27),
13. 3933893 - Derivatives of 9-phenanthrene (1976-01-20),

Title: **Arthur D. Sill: Pioneering Innovations in Pharmaceutical Agents**

Introduction

Arthur D. Sill is an esteemed inventor based in Cincinnati, OH, who has made significant contributions in the field of pharmaceuticals. With a total of 13 patents to his name, Sill is known for his innovative research and development of antiviral compounds. His work has paved the way for advancements in the treatment and prevention of viral infections.

Latest Patents

Among Sill's most notable patents are his latest innovations, which include the development of 2,7-Bis-basic ethers of 9-phenanthrol and 9-loweralkoxy phenanthrol. These novel bis-basic ethers of 9-substituted phenanthrene, along with their related 10-oxa and 10-aza derivatives, have been disclosed, showcasing their method of preparation and use as pharmaceutical agents. These compounds hold potential for the prevention and inhibition of viral infections.

Additionally, Sill has developed bis-basic ethers of 2,6,- and 2,7-dihydroxy-anthraquinones. These novel compounds and pharmaceutical formulations also demonstrate antiviral activity. The disclosed compounds have unique structural formulas that highlight their potential in the pharmaceutical landscape, particularly given the increasing necessity for effective antiviral treatments.

Career Highlights

Arthur D. Sill has dedicated his career to advancing pharmaceutical research. His position at Richardson-Merrell Inc. has allowed him to collaborate with leading professionals in the industry, further enhancing his contributions to science and medicine. Sill's expertise and innovative mindset have been instrumental in his success as an inventor.

Collaborations

Throughout his career, Sill has worked alongside prominent colleagues such as Robert W. Fleming and Francis W. Sweet. These collaborations have enriched his research efforts and facilitated the exploration of new ideas, significantly influencing the development of antiviral compounds.

Conclusion

In conclusion, Arthur D. Sill stands out as a leading inventor in the pharmaceutical arena. His 13 patents reflect his commitment to innovation and his relentless pursuit of solutions for viral infections. Through his work at Richardson-Merrell Inc. and his collaborations with esteemed colleagues, Sill continues to advance the field, making a lasting impact on pharmaceutical research and the treatment of viral diseases.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…